static-content.springer.com10.1007... · Web viewChristopher C.W. Hughes 1,2,3,4 Affiliations: 1The...
Transcript of static-content.springer.com10.1007... · Web viewChristopher C.W. Hughes 1,2,3,4 Affiliations: 1The...
Supplementary Data
Title: mTORC2 MEDIATES CXCL12-INDUCED ANGIOGENESIS
Authors: Mary E. Ziegler1, Michaela M.S. Hatch1, Nan Wu1, Steven A. Muawad1 and Christopher C.W. Hughes1,2,3,4
Affiliations:1The Department of Molecular Biology and Biochemistry, University of California Irvine, Irvine, CA 92697, USA2The Department of Biomedical Engineering, University of California Irvine, Irvine, CA 92697, USA3The Edwards Lifesciences Center for Advanced Cardiovascular Technology, University of California Irvine, Irvine, CA 92697, USA4Corresponding Author: Christopher C.W. Hughes Ph.D. [email protected]
Journal: Angiogenesis
1
Fig. S1 Optimization of CXCL12 stimulation
(a) Serum-starved EC were stimulated with CXCL12 (50 ng/ml) at various time points
(as indicated). Cell lysates were harvested and a Western blot was performed to
determine the phosphorylation of Akt (S473) and S6RP (S240/244). -actin was used as
a loading control. (b) Serum-starved EC were stimulated with CXCL12 for 30 min using
a range of concentrations (as indicated). Cell lysates were harvested and a Western blot
was performed to determine the phosphorylation of Akt (S473) and S6RP (S240/244). -
actin was used as a loading control. The experiment was repeated a minimum of 3 times
with similar results.
2
Fig. S2 CXCL12 does not significantly activate mTORC1
Serum-starved EC were either left untreated or stimulated with CXCL12 (50 ng/ml, 30
min). The lysates were harvested and a Western blot was performed to determine the
phosphorylation of S6RP (S240/244). -actin was used as a loading control. The bands
of the Western blot were quantified using NIH ImageJ. The phospho-bands were
normalized to the loading control and each condition is represented by average fold
change compared to the vehicle control. The images are from the same blot and
separated to present only the relevant treatment groups. The error bars represent the
SEM. The experiment was repeated a minimum of 3 times with similar results.
3
Fig. S3 The knockdown of raptor and rictor
ECs were transfected with either control, raptor or rictor siRNA. Seventy-two hours after
transfection the cell lysates were collected. A Western blot was performed to examine
the expression of raptor and rictor protein to determine the knockdown efficiency. Total
mTOR protein was used as a loading control. The bands were analyzed using NIH
ImageJ and normalized to mTOR. The percent expression was determined by
comparing the targets to the control siRNA.
4
Fig. S4 The knockdown of raptor and rictor using a second set of siRNAs
(a) ECs were transfected with either control, raptor or rictor siRNA. Seventy-two hours
after transfection the cell lysates were collected. A Western blot was performed to
examine the expression of raptor and rictor protein to determine the knockdown
efficiency. Total mTOR protein was used as a loading control. The bands were analyzed
using NIH ImageJ and normalized to mTOR. The percent expression was determined by
comparing the targets to the control siRNA. (b) EC were transfected with control, raptor
or rictor siRNA (an independent set compared to Figure 2). Twenty-four hours later a
fibrin sprouting assay (as described above) was performed. The beads were fixed at day
7 and imaged. The number of sprouts per bead was quantified. The error bars represent
the SEM (**p < 0.01). All experiments were repeated a minimum of 3 times with similar
results.
5
Figure S5. The knockdown of mTORC2 inhibits angiogenesis in vitro. (A and B) EC
were transfected with control, Rheb or Sin1 siRNA. Seventy-two hours after transfection
the cell lysates were collected. A Western blot was performed to examine the expression
of Rheb and Sin1 protein to determine the knockdown efficiency. -actin was used as a
loading control and the bands were analyzed using ImageJ. The percent expression was
determined by comparing the targets to the control siRNA.
6
Fig. S6 Rapamycin dose response
A western blot was performed on EC treated with a range of doses of rapamycin (as
indicated). The membrane was probed for S6RP (S240/244) and Akt (S473) to assess
for inhibition of mTORC1 and mTORC2, respectively. -actin was used as a loading
control. The bands of the Western blot were quantified using ImageJ. The phospho-
bands were normalized to the loading control and each condition is represented by
average fold change compared to the vehicle control. The error bars represent the SEM
(*p<0.05). All experiments were repeated a minimum of 3 times with similar results.
7
Fig. S7 Depletion of mTORC2 signaling by increasing the dose of rapamycin inhibits
sprouting in HMVEC
(a) HMVECs were coated onto Cytodex beads and embedded in a fibrin gel. NHLFs
were seeded on top of the fibrin gel. Twenty-four hours after embedding the cells were
treated with rapamycin as indicated. DMSO was used as a vehicle control. The inhibitor
was replaced with each medium change. (b) The beads were fixed at day 7 and the
number of sprouts per bead was quantified. Scale bar: 150 m. The error bars
represent the SEM (n = 2 independent experiments; ***p < 0.001).
8
Fig. S8 Pharmacological inhibition of mTOR does not reduce cell viability
EC we seeded into a 96-well plate and treated with vehicle, rapamycin (100nM) or
PP242 (600nM). After 48 hrs an XTT assay was performed and cell viability was
determined by measuring the OD at 450 nm. The results are presented at the percent
viability relative to the vehicle control. The error bars represent the SEM (n=3).
9
Fig. S9 CXCR4 is co-expressed with EC in vivo
The CT-26 control tumors described in Figure 5 were sectioned and stained with an anti-
CD31 antibody (left panel) and an anti-CXCR4 antibody (middle panel). A merged image
(right panel) of the staining was obtained along with a DAPI nuclear stain (blue) to show
the co-expression of CD31 and CXCR4 (yellow). The fluorescent images of the sections
were taken at 40X and are representative of the staining observed in the control tumors.
10
Fig. S10 High dose rapamycin blocks mTORC2 signaling and vessel infiltration in vivo
(a) EC within the tumor sections were visualized by staining for CD31+ cells. The
sections were imaged from one side of the tumor to the other to obtain the vascular
density for each image of the tumor as shown. (b) Using ImageJ, the degree of
vascularization was calculated at a relative distance into the tumor of 20%, 40%, 60%,
80% and 100% (where 100% was considered the center of the tumor). Error bars are the
SEM. n = 5-6 mice per group; (*p < 0.05).
11
Fig. S11 PFKFB3 expression in EC. EC were transfected with control or PFKFB3
siRNA. Seventy-two hours after transfection the cell lysates were collected. A Western
blot was performed to examine the expression of PFKFB3 protein to determine the
knockdown efficiency. -actin was used as the loading control. The bands were
analyzed using ImageJ and the percent expression was determined by comparing the
targets to the control siRNA.
12